STOCK TITAN
  1. Home
  2. Sec-filings
  3. GM
  4. [Form 4] General Motors Co Insider Trading Activity

GM insider sells shares after option exercises at ~$66 avg

Filing Impact
(Very High)
Filing Sentiment
(Very Negative)
Form Type
4

Rhea-AI Filing Summary

General Motors (GM): insider transaction — A company officer listed as President reported multiple transactions on 10/22/2025. The reporting person exercised 80,000 stock options at $39 and sold 80,000 common shares at a weighted average price of $66.46. They also exercised 147,570 stock options at $35.49 and sold 147,570 shares at a weighted average price of $66.46, followed by an additional sale of 33,030 shares at a weighted average price of $66.38.

Following these transactions, the reporting person beneficially owned 98,006 common shares directly. The exercised options were granted on February 13, 2019 (expiration 02/13/2029) and February 12, 2020 (expiration 02/12/2030), and are fully vested. Weighted average prices reflect multiple trades within disclosed ranges.

Positive

  • None.

Negative

  • None.
Insider Reuss Mark L
Role President
Sold 260,600 shs ($17.32M)
Type Security Shares Price Value
Exercise Employee Stock Option (Right to Buy) 80,000 $0.00 --
Exercise Employee Stock Option (Right to Buy) 147,570 $0.00 --
Exercise Common Stock 80,000 $39.00 $3.12M
Sale Common Stock 80,000 $66.46 $5.32M
Exercise Common Stock 147,570 $35.49 $5.24M
Sale Common Stock 147,570 $66.46 $9.81M
Sale Common Stock 33,030 $66.38 $2.19M
Holdings After Transaction: Employee Stock Option (Right to Buy) — 0 shares (Direct); Common Stock — 211,036 shares (Direct)
Footnotes (1)
  1. The price in Column 4 is the weighted average selling price of the shares. The shares were sold in multiple transactions at prices from $66.02 to $66.97, inclusive. The Reporting Person undertakes to provide to the SEC, GM and any security holder, upon request, full information regarding the number of shares sold at each price point within the ranges set forth in this footnote. The price in Column 4 is the weighted average selling price of the shares. The shares were sold in multiple transactions at prices from $65.96 to $66.98, inclusive. The Reporting Person undertakes to provide to the SEC, GM and any security holder, upon request, full information regarding the number of shares sold at each price point within the ranges set forth in this footnote. These stock options were granted on February 13, 2019 and are fully vested. These stock options were granted on February 12, 2020 and are fully vested.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Reuss Mark L
(Last) (First) (Middle)
300 RENAISSANCE CENTER
M/C: 482-C24-A68
(Street)
DETROIT MI 48265-3000
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
General Motors Co [ GM ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
President
3. Date of Earliest Transaction (Month/Day/Year)
10/22/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/22/2025 M 80,000 A $39 211,036 D
Common Stock 10/22/2025 S 80,000 D $66.46(1) 131,036 D
Common Stock 10/22/2025 M 147,570 A $35.49 278,606 D
Common Stock 10/22/2025 S 147,570 D $66.46(1) 131,036 D
Common Stock 10/22/2025 S 33,030 D $66.38(2) 98,006 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy) $39 10/22/2025 M 80,000 (3) 02/13/2029 Common Stock 80,000 $0 0 D
Employee Stock Option (Right to Buy) $35.49 10/22/2025 M 147,570 (4) 02/12/2030 Common Stock 147,570 $0 147,569 D
Explanation of Responses:
1. The price in Column 4 is the weighted average selling price of the shares. The shares were sold in multiple transactions at prices from $66.02 to $66.97, inclusive. The Reporting Person undertakes to provide to the SEC, GM and any security holder, upon request, full information regarding the number of shares sold at each price point within the ranges set forth in this footnote.
2. The price in Column 4 is the weighted average selling price of the shares. The shares were sold in multiple transactions at prices from $65.96 to $66.98, inclusive. The Reporting Person undertakes to provide to the SEC, GM and any security holder, upon request, full information regarding the number of shares sold at each price point within the ranges set forth in this footnote.
3. These stock options were granted on February 13, 2019 and are fully vested.
4. These stock options were granted on February 12, 2020 and are fully vested.
Remarks:
/s/ Tia Y. Turk, Attorney-In-Fact for Mr. Reuss 10/24/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What did GM (GM) disclose in this Form 4?

A company officer who is President exercised stock options and sold common shares on 10/22/2025, with weighted average sale prices disclosed.

How many GM shares did the insider sell on 10/22/2025?

80,000 shares at a weighted average of $66.46, 147,570 shares at $66.46, and 33,030 shares at $66.38.

How many GM shares does the reporting person own after the transactions?

Beneficial ownership reported as 98,006 common shares directly after the transactions.

What option exercises were reported for GM (GM)?

80,000 options exercised at $39 and 147,570 options exercised at $35.49 on 10/22/2025.

What are the grant and expiration dates of the exercised GM options?

Granted on 02/13/2019 (expires 02/13/2029) and 02/12/2020 (expires 02/12/2030); both are fully vested.

How were the GM sale prices calculated?

Reported as weighted averages, with sales executed across price ranges disclosed in the footnotes.